Literature DB >> 18826482

Asymptomatic bacteriuria and symptomatic urinary tract infections in pregnancy.

J Schnarr1, F Smaill.   

Abstract

Symptomatic and asymptomatic bacteriuria is common in pregnant women. A history of previous urinary tract infections and low socioeconomic status are risk factors for bacteriuria in pregnancy. Escherichia coli is the most common aetiologic agent in both symptomatic and asymptomatic infection and quantitative culture is the gold standard for diagnosis. Treatment of asymptomatic bacteriuria has been shown to reduce the rate of pyelonephritis in pregnancy and therefore screening for and treatment of asymptomatic bacteriuria has become a standard of obstetrical care. Antibiotic treatment of asymptomatic bacteriuria is associated with a decrease in the incidence of low birth weight, but the methodological quality of the studies limits the strength of the conclusions that can be drawn. Debate exists in the literature as to whether treated pyelonephritis is associated with adverse fetal outcomes. There is no clear consensus in the literature on antibiotic choice or duration of therapy for infection. With increasing antibiotic resistance, consideration of local resistance rates is necessary when choosing therapy.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18826482     DOI: 10.1111/j.1365-2362.2008.02009.x

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  52 in total

1.  Recommendations on screening for asymptomatic bacteriuria in pregnancy.

Authors:  Ainsley Moore; Marion Doull; Roland Grad; Stéphane Groulx; Kevin Pottie; Marcello Tonelli; Susan Courage; Alejandra Jaramillo Garcia; Brett D Thombs
Journal:  CMAJ       Date:  2018-07-09       Impact factor: 8.262

2.  Interactions among urogenital, intestinal, skin, and oral infections in pregnant and lactating Panamanian Ngäbe women: a neglected public health challenge.

Authors:  Doris González-Fernández; Kristine G Koski; Odalis Teresa Sinisterra; Emérita Del Carmen Pons; Enrique Murillo; Marilyn E Scott
Journal:  Am J Trop Med Hyg       Date:  2015-03-30       Impact factor: 2.345

3.  Use of trimethoprim-sulfamethoxazole during pregnancy and risk of spontaneous abortion: a nested case control study.

Authors:  Flory T Muanda; Odile Sheehy; Anick Bérard
Journal:  Br J Clin Pharmacol       Date:  2018-03-25       Impact factor: 4.335

Review 4.  The female urinary microbiota, urinary health and common urinary disorders.

Authors:  Linda Brubaker; Alan J Wolfe
Journal:  Ann Transl Med       Date:  2017-01

5.  Prevalence and Associated Risk Factors of Asymptomatic Bacteriuria in Ante-Natal Clients in a Large Teaching Hospital in Ghana.

Authors:  A-K Labi; A E Yawson; G Y Ganyaglo; M J Newman
Journal:  Ghana Med J       Date:  2015-09

Review 6.  Approach to a positive urine culture in a patient without urinary symptoms.

Authors:  Barbara W Trautner; Larissa Grigoryan
Journal:  Infect Dis Clin North Am       Date:  2013-12-08       Impact factor: 5.982

Review 7.  Routine blood cultures in the management of pyelonephritis in pregnancy for improving outcomes.

Authors:  Harumi Gomi; Yoshihito Goto; Malinee Laopaiboon; Rie Usui; Rintaro Mori
Journal:  Cochrane Database Syst Rev       Date:  2015-02-13

8.  Intakes of garlic and dried fruits are associated with lower risk of spontaneous preterm delivery.

Authors:  Ronny Myhre; Anne Lise Brantsæter; Solveig Myking; Merete Eggesbø; Helle Margrete Meltzer; Margaretha Haugen; Bo Jacobsson
Journal:  J Nutr       Date:  2013-05-22       Impact factor: 4.798

9.  A preliminary assessment of asymptomatic bacteriuria of pregnancy in brunei darussalam.

Authors:  Siti Hanna Muharram; Siti Nur Bazilah Ghazali; Hajah Roselina Yaakub; Oduola Abiola
Journal:  Malays J Med Sci       Date:  2014-03

10.  Discovery and Characterization of Human-Urine Utilization by Asymptomatic-Bacteriuria-Causing Streptococcus agalactiae.

Authors:  Deepak S Ipe; Nouri L Ben Zakour; Matthew J Sullivan; Scott A Beatson; Kimberly B Ulett; William H Benjamin; Mark R Davies; Samantha J Dando; Nathan P King; Allan W Cripps; Mark A Schembri; Gordon Dougan; Glen C Ulett
Journal:  Infect Immun       Date:  2015-11-09       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.